Targeting Symptoms With Targeted Agents in NSCLC: An Expert Interview With Dr. Ezra Cohen
14th Nov 2006, 21:52 GMT
In this Expert Interview with Dr. Ezra Cohen, the focus is on how targeted therapies make patients with NSCLC feel better and how the concept of "clinical benefit" is evolving. Medscape Hematology-Oncology
Targeting Symptoms With Targeted Agents in NSCLC: An Expert Interview With Dr. Ezra Cohen related news:
- Treating the Negative Symptoms of Schizophrenia: An Expert Interview With Joseph Coyle, MD — Medscape Pharmacist Headlines
- Treating the Negative Symptoms of Schizophrenia: An Expert Interview With James Coyle, MD — Medscape Psychiatry Headlines
- Expert: Free agents will be overpaid — MSNBC.com: Sports
- Respiratory Symptoms Strongly Predict More Persistent Cow's Milk Allergy — Medscape Allergy Headlines
- MHA Congratulates Dr Kimberly Binaso — Pharmaceuticals News from StratCenter.com
- Hugh Laurie breaks up post-SNL Borat beatdown — TV Squad
- A new Expert from Peugeot — Automotoportal.com RSS
- Teens Experience Cannabis Withdrawal Symptoms — Medscape PublicHealth Headlines
- Combination therapy appears more effective than single drug for lower urinary tract symptoms — EurekAlert! - Medicine and Health
- High-tech Spectroscopy May Be Used To Monitor Neuropsychiatric Symptoms — ScienceDaily Headlines: Health & Medicine